Use of the TMAO test often occurs for more accurate risk prediction of a major cardiac event in patients undergoing elective coronary angiography and patients with acute coronary syndromes.
Clinical data also supports using TMAO testing to get a clearer idea of the risk for all-cause mortality in patients with peripheral artery disease, heart failure, chronic kidney disease, and after a myocardial infarction.
To undergo the TMAO blood test, patients fast overnight and refrain from eating fish or other seafood — including fish oil or krill oil supplements — the day before the blood draw to avoid false elevations in TMAO.
After a blood draw, TMAO levels are assessed in micrometers (μM). A reading of less than 6.2 μM indicates low risk of a major cardiac event, and the higher that number, the greater the risk.